Good news for people with MS: COVID-19 vaccine not tied to relapse, study finds

Published on August 14, 2024

People with multiple sclerosis (MS) have an increased risk of severe coronavirus infection, but there has been concern regarding potential relapse after vaccination. A new study finds that people with MS may not have a higher risk of relapse after COVID-19 vaccination.

Continue reading on website
Other news

Shingles increases risk of subsequent cognitive decline, study suggests

August 14, 2024
This new study found that an episode of shingles is associated with about a 20 percent higher long-term risk of subjective cognitive decline.

Candidate malaria vaccine provides lasting protection in NIH-sponsored trials

August 14, 2024
Recent trials of an experimental malaria vaccine in healthy Malian adults found that all three tested regimens were safe. One of the trials enrolled 300 healthy women ages 18 to 38 years who anticipated becoming pregnant soon after immunization. That trial began with drug treatment to remove malaria parasites, followed by three injections spaced over a month of either saline placebo or the investi